| Followers | 57 |
| Posts | 11147 |
| Boards Moderated | 2 |
| Alias Born | 04/25/2012 |
Thursday, June 03, 2021 9:51:33 AM
Wanting a sniff test from you.
(Not like that.
)
I have no basis with which to judge the potential efficacy or lack thereof.
CRXM has a Stop Sign but are making progress toward getting current.
At least 50M shares out there now. Dilution daily but it's a kinder-and-gentler dilution. Channels consistently in the $0.04 to $0.05 range. We're talking sub-$5M market cap and it's going into Phase 3 at the beginning of next year. Might be 5 years away from competing with Ranexa (reportedly the only drug that does what Generx hopes to do) but I figure once they get current, it's worth a solid bump in market cap. Lots of crap out there with $50M market cap and no path to success.
https://genebiotherapeutics.com/wp-content/uploads/2021/04/Gene-Biotherapeutics-Investor-Presentation.pdf
(Not like that.
) I have no basis with which to judge the potential efficacy or lack thereof.
CRXM has a Stop Sign but are making progress toward getting current.
At least 50M shares out there now. Dilution daily but it's a kinder-and-gentler dilution. Channels consistently in the $0.04 to $0.05 range. We're talking sub-$5M market cap and it's going into Phase 3 at the beginning of next year. Might be 5 years away from competing with Ranexa (reportedly the only drug that does what Generx hopes to do) but I figure once they get current, it's worth a solid bump in market cap. Lots of crap out there with $50M market cap and no path to success.
https://genebiotherapeutics.com/wp-content/uploads/2021/04/Gene-Biotherapeutics-Investor-Presentation.pdf
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
